Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
Bo‐Ram Jin, Hyo‐Jin An
Aging (2020) Vol. 12, Iss. 3, pp. 2142-2155
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Baicalin mediated regulation of key signaling pathways in cancer
Shilpi Singh, Abha Meena, Suaib Luqman
Pharmacological Research (2020) Vol. 164, pp. 105387-105387
Closed Access | Times Cited: 108
Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats
Luyao Li, Jie Han, Lan Wu, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis
Mohamed El‐Sherbiny, Mohamed El‐Shafey, Mosaab Salah El-din El-Agawy, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108082-108082
Closed Access | Times Cited: 34
Prostate cancer: Therapeutic prospect with herbal medicine
Suvranil Ghosh, Joyita Hazra, Koustav Pal, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100034-100034
Open Access | Times Cited: 33
Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR–NLRP3 pathway
Bo‐Ram Jin, Chae-Young Lim, Hyo-Jung Kim, et al.
Redox Biology (2023) Vol. 65, pp. 102816-102816
Open Access | Times Cited: 14
The human microbiome and benign prostatic hyperplasia: Current understandings and clinical implications
Jiaren Li, Youyou Li, Liang Zhou, et al.
Microbiological Research (2024) Vol. 281, pp. 127596-127596
Closed Access | Times Cited: 5
Ondansetron Alleviates Testosterone-Induced BPH in Rats Through Cross Regulation of the 5-HT/AR/P-STAT3 and the Non-Canonical NF-κB Pathways
Reem A. Mohamed, Maha Shouman
European Journal of Pharmacology (2025) Vol. 991, pp. 177331-177331
Closed Access
Black phosphorus nanosheets encapsulated microneedle for multifunctional therapy for androgenic alopecia
Sha Xiong, Zhongjun Li, Siwen Jiao, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Chemopreventive Potential of Paddy Waste: A Promising Approach Against Benign Prostate Hyperplasia in Spontaneously Hypertensive Rats
Azman Seeni, Atif Amin Baig, Mogana Das Murtey
Analytical Cellular Pathology (2025) Vol. 2025, Iss. 1
Open Access
Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress
Randa Hisham Aljorani, Adeeb Ahmed Al-Zubaidy, Nibrass Taher Abdali
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2025) Vol. 8, Iss. 2, pp. 35-41
Closed Access
Ripasudil, a Rho kinase inhibitor, attenuates testosterone-induced benign prostatic hyperplasia in rats: targeting inflammation, oxidative stress, and Rho kinase pathways
Randa Hisham Aljorani, Adeeb Ahmed Al-Zubaidy, Nibrass Taher Abdali
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo
Anqi Zeng, Xin Liang, Shaomi Zhu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 29
Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway
Yi Hou, Chao Pi, Xianhu Feng, et al.
Molecular Therapy — Oncolytics (2020) Vol. 19, pp. 67-78
Open Access | Times Cited: 26
The consequence and mechanism of dietary flavonoids on androgen profiles and disorders amelioration
Xiang Hu, Xusheng Li, Pan Deng, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 32, pp. 11327-11350
Closed Access | Times Cited: 14
New Pimarane Diterpenoids Isolated from EtOAc-Extract of Apiospora arundinis Culture Medium Show Antibenign Prostatic Hyperplasia Potential
Haeun Kwon, Bo‐Ram Jin, Hyo-Jung Kim, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5616-5623
Open Access | Times Cited: 2
Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells
Mao‐Si Fan, Yue-fei Xia, Rui-Han Ye, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 803-803
Open Access | Times Cited: 5
17β-Estradiol, through activating the G protein-coupled estrogen receptor, exacerbates the complication of benign prostatic hyperplasia in type 2 diabetes mellitus patients by inducing prostate proliferation
Tingting Yang, Zhen Qiu, Jiaming Shen, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 9, pp. 100962-100962
Open Access | Times Cited: 1
The effect of Jiedu Huoxue decoction on rat model of experimental nonbacterial prostatitis via regulation of miRNAs
Zhangren Yan, Chunhua Huang, Gang Huang, et al.
Pharmaceutical Biology (2020) Vol. 58, Iss. 1, pp. 745-759
Open Access | Times Cited: 9
The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition
Jinglou Chen, Nan Rong, Min Liu, et al.
Toxicology and Applied Pharmacology (2020) Vol. 411, pp. 115384-115384
Closed Access | Times Cited: 8
SH‐PRO extract alleviates benign prostatic hyperplasia via ROS‐mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo
Ji Eon Park, Woo‐Cheol Shin, Hyo‐Jung Lee, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 452-463
Closed Access | Times Cited: 5
Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
Bo‐Ram Jin, Hyo‐Jin An
Aging (2021) Vol. 13, Iss. 16, pp. 20016-20028
Open Access | Times Cited: 7
The role of phytoandrogens for benign prostatic hyperplasia treatment
Yaoxin Wu, Nuttapong Wichai, Xiaohua Yang, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 1, pp. 28-37
Open Access | Times Cited: 2
Revisiting monoamine oxidase inhibitors: A potential dual-action therapy for patients with prostate cancer and comorbid depression?
Přemysl Vlček, Petr Bob, Karel Valeš
Journal of Psychopharmacology (2023) Vol. 37, Iss. 11, pp. 1157-1160
Closed Access | Times Cited: 2
Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
Zhanliang Liu, Zhemin Lin, Fang Cao, et al.
BMC Urology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Analysis of the Beneficial Effects of Probiotics on the Gut–Prostate Axis Using Prostatic Co-Culture Model
Sara Ferrari, Rebecca Galla, Simone Mulè, et al.
Foods (2024) Vol. 13, Iss. 22, pp. 3647-3647
Open Access
Page 1 - Next Page

Scroll to top